Tony Baxter

DName-IT NV engages in the research and development of genetic diagnostic tests. It offers D name molecules, accessory consumables, and software for improving the quality of workflow of genetic diagnostic tests based on next generation sequencing. The company was founded by Harry Cuppens on December 11, 2014 and is headquartered in Leuven, Belgium.

DName-IT NV engages in the research and development of genetic diagnostic tests. It offers D name molecules, accessory consumables, and software for improving the quality of workflow of genetic diagnostic tests based on next generation sequencing. The company was founded by Harry Cuppens on December 11, 2014 and is headquartered in Leuven, Belgium.

DName-IT NV engages in the research and development of genetic diagnostic tests. It offers D name molecules, accessory consumables, and software for improving the quality of workflow of genetic diagnostic tests based on next generation sequencing. The company was founded by Harry Cuppens on December 11, 2014 and is headquartered in Leuven, Belgium.

DName-IT NV engages in the research and development of genetic diagnostic tests. It offers D name molecules, accessory consumables, and software for improving the quality of workflow of genetic diagnostic tests based on next generation sequencing. The company was founded by Harry Cuppens on December 11, 2014 and is headquartered in Leuven, Belgium.

DName-IT NV engages in the research and development of genetic diagnostic tests. It offers D name molecules, accessory consumables, and software for improving the quality of workflow of genetic diagnostic tests based on next generation sequencing. The company was founded by Harry Cuppens on December 11, 2014 and is headquartered in Leuven, Belgium.